Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine

Wan Rosalina Wan Rosli, Lay Kek Teh, Norsarwany Mohamad, Ariffin Nasir, Rozita Yusoff, Aziz Baba, Mohd Zaki Salleh

Journal of Clinical Pharmacy and Therapeutics · 2011 · 47 citations · 10 references

Abstract

Our results suggest that ITPA 94C>A testing, but not TPMT testing, may help in minimizing the adverse effects of 6-MP in Malaysian patients. However, whether this is true in clinical practice requires a larger study and formal randomized controlled evaluation.

References

10